- Home
- ALEC vs NEN Comparison
ALEC vs NEN Comparison
Compare ALEC & NEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
NEN
New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership
Current Price
Company Overview
Basic Information| Metric | ALEC | NEN |
|---|---|---|
| Founded | 2013 | 1977 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Building operators |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 262.7M | 227.9M |
| IPO Year | 2019 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ALEC | NEN |
|---|---|---|
| Price | $2.72 | $59.00 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $4.83 | N/A |
| AVG Volume (30 Days) | ★ 614.7K | 1.3K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.71% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $21,045,000.00 | ★ $89,196,544.00 |
| Revenue This Year | $18.36 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $19.68 |
| Revenue Growth | N/A | ★ 10.76 |
| 52 Week Low | $0.98 | $56.00 |
| 52 Week High | $3.40 | $80.01 |
Technical Indicators
Market Signals| Indicator | ALEC | NEN |
|---|---|---|
| Relative Strength Index (RSI) | 66.10 | 42.65 |
| Support Level | $1.89 | $56.00 |
| Resistance Level | $3.34 | $66.90 |
| Average True Range (ATR) | 0.19 | 1.17 |
| MACD | 0.03 | -0.03 |
| Stochastic Oscillator | 96.68 | 43.17 |
Price Performance
Historical ComparisonAbout ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
About NEN New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership
New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating and selling real estate. The Partnership owns and operates various residential apartments, condominium units and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.